Jon Fleetwood
Jon FleetwoodIndependent research journalism exposing health & political systems weaponized against Americans. Seen on RFK Jr.'s Children's Health Defense, Alex Jones' InfoWars, One America News, The Tennpenny Report, Mike Lindell's Frank Speech, & The New American.
| Platform |  | Pricing | Only free issues |
|---|---|---|---|
| Publishes | Daily | Issues | 394 |
| Subscribers | Read | jonfleetwood.substack.com |
Curious about how many subscribers Jon Fleetwood has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Chart Rankings
How this newsletter ranks in the official Substack charts.
| #141 | |
| #236 |
Latest Issues
Recent posts by this newsletter. Browse the email archive.
Texas Lawmaker Pushes for Prescription-Free Ivermectin in New Bill: HB 3175
Texas lawmakers are considering a major shift in access to ivermectin, as State Representative Wes Virdell (R-53) on Friday introduced House Bill 3175 (HB 3175), a bill that would allow pharmacists to dispense the drug without a prescriptio...
Canada Buys 500,000 Formaldehyde- and Mercury-Containing Bird Flu Vaccines Amid Internationally Coordinated Pandemic Push
The Public Health Agency of Canada (PHAC) has purchased 500,000 doses of GSK’s human vaccine against H5N1 avian influenza bird flu, ArepanrixTM.
BlackRock, Vanguard Hold 13 Million Shares in Trump Media Corp Valued at $350 Million
BlackRock and Vanguard—two of the world’s largest asset managers, both affiliated with the World Economic Forum (WEF)—are among the top institutional shareholders of Trump Media & Technology Group Corp. (DJT), the publicly traded company be...
Disease-Causing COVID Jab Spike Protein Stays in Body 709 Days: Yale Researchers
A new preprint study from Yale University School of Medicine confirms that the disease-causing spike protein produced by the COVID-19 injections can persist in the body for nearly two years after vaccination.
Authors
The writers behind this newsletter.
Frequently Asked Questions
How can I access the email archive for Jon Fleetwood?
You can find recent issues that have been published by Jon Fleetwood on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Jon Fleetwood have?
To see how many people subscribe to Jon Fleetwood, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Jon Fleetwood?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Jon Fleetwood as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Jon Fleetwood?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Jon Fleetwood using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to Jon Fleetwood?
Scroll up to where it says Similar Newsletters to see other publications like Jon Fleetwood. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Jon Fleetwood?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.